Targeting Adenosine A2A Receptors in Parkinson's Disease

Abstract

In pursuit of an improved understanding and treatment of Parkinson's disease (PD) and related neuropsychiatric disease we have held a translational research conference entitled, "Targeting Adenosine A2A Receptors in ParkThson's Disease and other CNS Disorders" in Boston, May 17-19, 2006. Recent insights into the ONS functions of the adenosine A2A receptor, A2A receptor neurotoxicology, and intriguing environmental clues have all converged to markedly enhance the potential of A2A antagonists as a therapeutic strategy for PD. The goal of this conference was to facilitate the translation of advances in A2A receptor biology into improved therapy for PD by promoting the exchange of ideas on the basic science and clinical study of this molecular target.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Nov 01, 2006
Accession Number
ADA452764

Entities

People

  • Michael A Schwarzschild

Organizations

  • Massachusetts General Hospital

Tags

Communities of Interest

  • Energy and Power Technologies

DTIC Thesaurus Topics

  • Brain
  • Brain Injuries
  • Cells
  • Chemical Synthesis
  • Chemistry
  • Drug Abuse
  • Health Services
  • Human Behavior
  • Neurodegeneration
  • Neurons
  • Neurosciences
  • Parkinson'S Disease

Fields of Study

  • Biology
  • Medicine

Readers

  • Neurodegenerative Parkinson's Disease and Rickettsial Disease handbook, including the data level of dopamine, BC, neurons, and PD.
  • Neuroscience
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.